The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages
Abstract Objectives C‐reactive protein (CRP) is a well‐known acute‐phase protein that increases remarkably under various inflammatory conditions and is elevated in patients with malignant tumors. In this study, we investigated the influence of CRP on the tumor microenvironment in clear cell renal ce...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Clinical & Translational Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cti2.70013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850116698067173376 |
|---|---|
| author | Cheng Pan Yukio Fujiwara Hiromu Yano Toshiki Anami Yuki Ibe Lianbo Li Yuji Miura Takanobu Motoshima Shigeyuki Esumi Junji Yatsuda Taizo Hibi Tomomi Kamba Yoshihiro Komohara |
| author_facet | Cheng Pan Yukio Fujiwara Hiromu Yano Toshiki Anami Yuki Ibe Lianbo Li Yuji Miura Takanobu Motoshima Shigeyuki Esumi Junji Yatsuda Taizo Hibi Tomomi Kamba Yoshihiro Komohara |
| author_sort | Cheng Pan |
| collection | DOAJ |
| description | Abstract Objectives C‐reactive protein (CRP) is a well‐known acute‐phase protein that increases remarkably under various inflammatory conditions and is elevated in patients with malignant tumors. In this study, we investigated the influence of CRP on the tumor microenvironment in clear cell renal cell carcinoma (ccRCC). Methods This study explored CRP's role in ccRCC by co‐culturing human macrophages with ccRCC cells and employing antibody blocking, RNA sequencing and in vitro experiments for functional insights. We also analysed The Cancer Genome Atlas Program (TCGA) data to link CD64 expression with ccRCC prognosis and used immunohistochemistry to associate CD64+ macrophages with tumor severity and systemic CRP levels. Results A co‐culture study using human macrophages and RCC cell lines showed that CRP‐stimulated macrophages secrete IL‐6, which induces RCC proliferation via STAT3 activation. CRP‐induced protumor activation of macrophages was suppressed by CD64 blocking antibodies. Furthermore, CRP elevates PD‐L1 expression in macrophages via the CD64‐STAT1 signalling pathway. Statistical analysis of TCGA data indicated that increased CD64 expression was associated with a worse clinical course in ccRCC. Immunohistochemical analysis of pathological specimens revealed that high CD64 expression in tumor‐associated macrophages (TAMs), and a high density of CD64+ TAMs, was linked to high nuclear grade and stage. High CD64 expression was also correlated with increased serum CRP levels. Conclusions The CRP‐CD64 signal was linked to the protumor activation of TAMs and could be a promising target for anticancer immunotherapy in ccRCC. |
| format | Article |
| id | doaj-art-9621d11915cf40d18cdc4f89fa59a864 |
| institution | OA Journals |
| issn | 2050-0068 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical & Translational Immunology |
| spelling | doaj-art-9621d11915cf40d18cdc4f89fa59a8642025-08-20T02:36:15ZengWileyClinical & Translational Immunology2050-00682024-01-011311n/an/a10.1002/cti2.70013The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophagesCheng Pan0Yukio Fujiwara1Hiromu Yano2Toshiki Anami3Yuki Ibe4Lianbo Li5Yuji Miura6Takanobu Motoshima7Shigeyuki Esumi8Junji Yatsuda9Taizo Hibi10Tomomi Kamba11Yoshihiro Komohara12Department of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Urology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Anatomy and Neurobiology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Urology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Pediatric Surgery and Transplantation, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Urology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanDepartment of Cell Pathology, Graduate School of Medical Sciences Kumamoto University Kumamoto JapanAbstract Objectives C‐reactive protein (CRP) is a well‐known acute‐phase protein that increases remarkably under various inflammatory conditions and is elevated in patients with malignant tumors. In this study, we investigated the influence of CRP on the tumor microenvironment in clear cell renal cell carcinoma (ccRCC). Methods This study explored CRP's role in ccRCC by co‐culturing human macrophages with ccRCC cells and employing antibody blocking, RNA sequencing and in vitro experiments for functional insights. We also analysed The Cancer Genome Atlas Program (TCGA) data to link CD64 expression with ccRCC prognosis and used immunohistochemistry to associate CD64+ macrophages with tumor severity and systemic CRP levels. Results A co‐culture study using human macrophages and RCC cell lines showed that CRP‐stimulated macrophages secrete IL‐6, which induces RCC proliferation via STAT3 activation. CRP‐induced protumor activation of macrophages was suppressed by CD64 blocking antibodies. Furthermore, CRP elevates PD‐L1 expression in macrophages via the CD64‐STAT1 signalling pathway. Statistical analysis of TCGA data indicated that increased CD64 expression was associated with a worse clinical course in ccRCC. Immunohistochemical analysis of pathological specimens revealed that high CD64 expression in tumor‐associated macrophages (TAMs), and a high density of CD64+ TAMs, was linked to high nuclear grade and stage. High CD64 expression was also correlated with increased serum CRP levels. Conclusions The CRP‐CD64 signal was linked to the protumor activation of TAMs and could be a promising target for anticancer immunotherapy in ccRCC.https://doi.org/10.1002/cti2.70013CD64CRPIL6macrophagePD‐L1renal cell carcinoma |
| spellingShingle | Cheng Pan Yukio Fujiwara Hiromu Yano Toshiki Anami Yuki Ibe Lianbo Li Yuji Miura Takanobu Motoshima Shigeyuki Esumi Junji Yatsuda Taizo Hibi Tomomi Kamba Yoshihiro Komohara The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages Clinical & Translational Immunology CD64 CRP IL6 macrophage PD‐L1 renal cell carcinoma |
| title | The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages |
| title_full | The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages |
| title_fullStr | The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages |
| title_full_unstemmed | The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages |
| title_short | The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor‐associated macrophages |
| title_sort | contribution of the crp cd64 axis to renal cancer progression by inducing protumor activation of tumor associated macrophages |
| topic | CD64 CRP IL6 macrophage PD‐L1 renal cell carcinoma |
| url | https://doi.org/10.1002/cti2.70013 |
| work_keys_str_mv | AT chengpan thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yukiofujiwara thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT hiromuyano thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT toshikianami thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yukiibe thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT lianboli thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yujimiura thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT takanobumotoshima thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT shigeyukiesumi thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT junjiyatsuda thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT taizohibi thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT tomomikamba thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yoshihirokomohara thecontributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT chengpan contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yukiofujiwara contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT hiromuyano contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT toshikianami contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yukiibe contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT lianboli contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yujimiura contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT takanobumotoshima contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT shigeyukiesumi contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT junjiyatsuda contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT taizohibi contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT tomomikamba contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages AT yoshihirokomohara contributionofthecrpcd64axistorenalcancerprogressionbyinducingprotumoractivationoftumorassociatedmacrophages |